Roivant Reports Q3 Results, Cites Phase 2 Breakthrough and Catalyst-Rich 2026
Roivant Sciences (Nasdaq: ROIV) reported its financial results for the fiscal third quarter ended December 31, 2025, underscored by positive...
5 articles, transcripts, and reports
Roivant Sciences (Nasdaq: ROIV) reported its financial results for the fiscal third quarter ended December 31, 2025, underscored by positive...
Roivant Sciences (Nasdaq: ROIV) on Friday reported its financial results for the fiscal third quarter ended December 31, 2025, revealing...
Roivant Sciences (NASDAQ: ROIV) Q2 2026 Earnings Conference
Roivant Sciences (NASDAQ: ROIV) Q3 2025 Earnings Call dated Feb. 10, 2025 Corporate Participants: Stephanie Lee Griffin — Chief Operating Officer, Roivant Platforms Matt Gline…
Roivant Sciences (NASDAQ: ROIV) Q4 2025 Earnings Call dated May. 29, 2025 Corporate Participants: Stephanie Lee — Investor Relations Matt Gline — Chief Executive Officer…